Health Law Matters

CMS to Revamp Hospital Star Rating System, But will Maintain Current Methodology for 2020

The Week In Health Law

  • The Centers for Medicare and Medicaid Services (“CMS”) announced its intention to update the quality measurement methodology for the Star Ratings system used to rate hospitals, which is located on CMS’s Hospital Compare website. While the update is to occur in 2021, CMS also indicated it will “refresh the Star Ratings using the current methodology in 2020.”
  • The star ratings were last released in February of this year, along with a public input request seeking feedback on potential changes. In response, a number of major health systems urged CMS to remove the Star Ratings from Hospital Compare until the methodology updates are made. As reported by Modern Healthcare, several systems are upset that CMS will proceed with using the current methodology to provide the 2020 ratings, while at the same time having acknowledged the methodology is in need of updating.  
  • According to a CMS spokeswoman, the agency has “full confidence” in the current star ratings methodology: “CMS believes that it is important to have updated star ratings information available for patients and consumers while we work to update the methodology.” CMS is hosting a listening session on September 19 to discuss comments from the public input request.

More trending Health Law topics this week:

  • Doctor Relationships with Device Makers may be Ripe for Fraud Litigation

Post a comment:

*All fields are required.

Ask the Blogger

Type the following characters: whisky, november, five, sierra, romeo, five

Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.

Attorney Spotlight

Brian F. Higgins is an associate in FBT's regulated business group with a focus on health care, and he has a history as corporate counsel to Medpace, Inc., a pharmaceutical clinical research organization.